IceCure Medical Ltd (ICCM)
USD 1.14
(-7.67%)
USD 1.14
(-7.67%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.22 Million USD | 4.67% |
| 2022 | 3.08 Million USD | -25.45% |
| 2021 | 4.13 Million USD | 1.31% |
| 2020 | 4.08 Million ILS | 146.41% |
| 2019 | 1.65 Million ILS | 54.64% |
| 2018 | 1.07 Million ILS | 55.49% |
| 2017 | 689.37 Thousand ILS | 10.21% |
| 2016 | 625.48 Thousand ILS | -18.01% |
| 2015 | 762.87 Thousand ILS | -28.61% |
| 2014 | 1.06 Million ILS | 201.32% |
| 2013 | 354.63 Thousand ILS | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 736.35 Thousand USD | -44.26% |
| 2024 Q2 | 996.84 Thousand USD | 37.3% |
| 2023 Q3 | 327 Thousand USD | -65.1% |
| 2023 FY | 3.22 Million USD | 4.67% |
| 2023 Q1 | 710 Thousand USD | -24.39% |
| 2023 Q2 | 937 Thousand USD | 31.97% |
| 2023 Q4 | 1.32 Million USD | 304.0% |
| 2022 Q2 | 765 Thousand USD | 2.41% |
| 2022 FY | 3.08 Million USD | -25.45% |
| 2022 Q4 | 939 Thousand USD | 48.11% |
| 2022 Q1 | 747 Thousand USD | -46.03% |
| 2022 Q3 | 634 Thousand USD | -17.12% |
| 2021 Q4 | 1.38 Million USD | 103.23% |
| 2021 Q2 | 637 Thousand USD | -55.64% |
| 2021 Q1 | 1.43 Million USD | 4.21% |
| 2021 FY | 4.13 Million USD | 1.31% |
| 2021 Q3 | 681 Thousand USD | 6.91% |
| 2020 FY | 4.08 Million ILS | 146.41% |
| 2020 Q4 | 1.37 Million USD | 117.01% |
| 2020 Q2 | 927.5 Thousand USD | 0.0% |
| 2020 Q1 | 927.5 Thousand USD | 72.02% |
| 2020 Q3 | 635 Thousand USD | -31.54% |
| 2019 Q3 | 535.64 Thousand USD | 89.65% |
| 2019 Q4 | 539.19 Thousand USD | 0.66% |
| 2019 FY | 1.65 Million ILS | 54.64% |
| 2019 Q2 | 282.43 Thousand USD | 1.79% |
| 2019 Q1 | 277.47 Thousand USD | -16.45% |
| 2018 Q1 | 251.74 Thousand USD | 331.52% |
| 2018 FY | 1.07 Million ILS | 55.49% |
| 2018 Q4 | 332.12 Thousand USD | 16.5% |
| 2018 Q3 | 285.09 Thousand USD | 18.65% |
| 2018 Q2 | 240.27 Thousand USD | -4.56% |
| 2017 Q3 | 171.41 Thousand USD | -24.64% |
| 2017 FY | 689.37 Thousand ILS | 10.21% |
| 2017 Q4 | 58.34 Thousand USD | -65.97% |
| 2017 Q1 | 219.08 Thousand USD | 142.29% |
| 2017 Q2 | 227.47 Thousand USD | 3.83% |
| 2016 Q4 | 90.42 Thousand USD | -55.48% |
| 2016 Q1 | 178.21 Thousand USD | -27.39% |
| 2016 Q2 | 162.55 Thousand USD | -8.79% |
| 2016 Q3 | 203.08 Thousand USD | 24.94% |
| 2016 FY | 625.48 Thousand ILS | -18.01% |
| 2015 Q3 | 160.51 Thousand USD | 8.91% |
| 2015 Q4 | 245.43 Thousand USD | 52.91% |
| 2015 Q2 | 147.38 Thousand USD | -29.97% |
| 2015 Q1 | 210.47 Thousand USD | -40.23% |
| 2015 FY | 762.87 Thousand ILS | -28.61% |
| 2014 Q3 | 355.38 Thousand USD | -2.18% |
| 2014 FY | 1.06 Million ILS | 201.32% |
| 2014 Q1 | 67.04 Thousand USD | -20.65% |
| 2014 Q2 | 363.31 Thousand USD | 441.88% |
| 2014 Q4 | 352.12 Thousand USD | -0.92% |
| 2013 Q4 | 84.49 Thousand USD | -44.72% |
| 2013 Q1 | 51.28 Thousand USD | -5.67% |
| 2013 FY | 354.63 Thousand ILS | 0.0% |
| 2013 Q2 | 59.4 Thousand USD | 15.84% |
| 2013 Q3 | 152.84 Thousand USD | 157.28% |
| 2012 Q4 | 54.36 Thousand USD | -42.09% |
| 2012 Q3 | 93.88 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 73.223% |
| BrainsWay Ltd. | 31.78 Million USD | 89.841% |
| Cerus Corporation | 156.36 Million USD | 97.935% |
| Envoy Medical, Inc. | 316 Thousand USD | -921.835% |
| electroCore, Inc. | 16.03 Million USD | 79.857% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -401.398% |
| Inogen, Inc. | 315.66 Million USD | 98.977% |
| OrthoPediatrics Corp. | 148.73 Million USD | 97.829% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -32.99% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -784.66% |
| MaxCyte, Inc. | 41.28 Million USD | 92.179% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -65.383% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -2815.628% |
| Orthofix Medical Inc. | 746.64 Million USD | 99.568% |
| PAVmed Inc | 2.45 Million USD | -31.688% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 85.661% |
| RxSight, Inc. | 89.07 Million USD | 96.375% |
| Sight Sciences, Inc. | 81.05 Million USD | 96.016% |
| SI-BONE, Inc. | 138.88 Million USD | 97.675% |
| TELA Bio, Inc. | 58.45 Million USD | 94.476% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 98.274% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 76.603% |
| Acutus Medical, Inc. | 7.16 Million USD | 54.927% |
| Talis Biomedical Corporation | 412 Thousand USD | -683.738% |
| Spectral AI, Inc. | 18.05 Million USD | 82.117% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 67.4% |
| CVRx, Inc. | 39.29 Million USD | 91.783% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -233.331% |
| Bioventus Inc. | 512.34 Million USD | 99.37% |
| Venus Concept Inc. | 76.35 Million USD | 95.771% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 82.556% |
| LivaNova PLC | 1.15 Billion USD | 99.72% |
| 908 Devices Inc. | 50.22 Million USD | 93.571% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 99.33% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -4091.112% |
| NeuroPace, Inc. | 65.42 Million USD | 95.064% |
| LENSAR, Inc. | 42.16 Million USD | 92.342% |
| Apyx Medical Corporation | 52.34 Million USD | 93.832% |
| Cutera, Inc. | 212.36 Million USD | 98.48% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 90.32% |
| BioSig Technologies, Inc. | 18 Thousand USD | -17838.889% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 98.063% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 86.521% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.791% |
| Axonics, Inc. | 366.37 Million USD | 99.119% |
| Outset Medical, Inc. | 130.37 Million USD | 97.523% |
| IRIDEX Corporation | 51.86 Million USD | 93.775% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 97.629% |
| IRadimed Corporation | 65.56 Million USD | 95.075% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -174.575% |
| INVO Bioscience, Inc. | 3.02 Million USD | -6.9% |
| Telesis Bio, Inc. | 27.5 Million USD | 88.262% |
| Viemed Healthcare, Inc. | 183 Million USD | 98.236% |
| Varex Imaging Corporation | 811 Million USD | 99.602% |
| Quipt Home Medical Corp. | 221.74 Million USD | 98.544% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 95.298% |
| Dynatronics Corporation | 32.53 Million USD | 90.075% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | 62.791% |
| Semler Scientific, Inc. | 68.18 Million USD | 95.264% |
| InMode Ltd. | 492.04 Million USD | 99.344% |
| Bruker Corporation | 2.96 Billion USD | 99.891% |
| Cytosorbents Corporation | 36.34 Million USD | 91.117% |
| DexCom, Inc. | 3.62 Billion USD | 99.911% |
| Align Technology, Inc. | 3.86 Billion USD | 99.916% |
| Viveve Medical, Inc. | 6.42 Million USD | 49.751% |
| ZimVie Inc. | 457.43 Million USD | 99.294% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 98.327% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -2815.628% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.568% |
| Profound Medical Corp. | 7.33 Million USD | 55.954% |
| Insulet Corporation | 1.69 Billion USD | 99.81% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 97.439% |
| iCAD, Inc. | 17.31 Million USD | 81.355% |
| Nuwellis, Inc. | 8.86 Million USD | 63.572% |
| Biotricity, Inc. | 12.06 Million USD | 73.233% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 99.345% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | 47.961% |
| PAVmed Inc. | 2.45 Million USD | -31.688% |
| BIOLASE, Inc. | 49.16 Million USD | 93.432% |
| Beyond Air, Inc. | 1.15 Million USD | -178.602% |
| FONAR Corporation | 102.88 Million USD | 96.862% |
| AxoGen, Inc. | 159.01 Million USD | 97.969% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 98.823% |
| Inari Medical, Inc. | 493.63 Million USD | 99.346% |
| UFP Technologies, Inc. | 400.07 Million USD | 99.193% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -17260.215% |
| Tenon Medical, Inc. | 2.92 Million USD | -10.28% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | 52.599% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.899% |
| Sintx Technologies, Inc. | 2.62 Million USD | -22.916% |
| NanoVibronix, Inc. | 2.28 Million USD | -41.437% |
| Quanterix Corporation | 122.36 Million USD | 97.361% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 86.769% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 98.39% |
| TransMedics Group, Inc. | 241.62 Million USD | 98.664% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 76.693% |
| NeuroMetrix, Inc. | 5.9 Million USD | 45.284% |
| Hyperfine, Inc. | 11.03 Million USD | 70.731% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 98.045% |
| Biomerica, Inc. | 5.41 Million USD | 40.369% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 93.614% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 98.177% |